Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Report this comment to a moderator

Please fill in the form below if you think a comment is unsuitable. Please indicate which comment is of concern and why. Your comments will be sent to our moderator for review.

Report comment to moderator

MandatoryRequired fields.


Case study: an error with a medicine containing arachis oil


I note the poster contains an image of Cerumol. It is useful to note that Cerumol ear drops (as a P product) were discontinued in Dec 2018 and the product was reformulated to remove the arachis oil. It is now Cerumol ear drops as a registered medical device and contains: Propylene Glycol Dicaprylocaprate, Butoxyl, Turpentine Oil, Chlorocresol and so is safe for use in patients with peanut or soya allergies.

Posted date

5 JAN 2021

Posted time



Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.